Alexion Pharmaceuticals, Inc. Company Profile

03:14 EST 12th December 2018 | BioPortfolio

Fourth Quarter 2011 Financial Highlights:

News Articles [444 Associated News Articles listed on BioPortfolio]

Alexion Pharmaceuticals Turns Lower Despite Upbeat Q3 Earnings, Guidance

WASHINGTON (dpa-AFX) - After seeing initial strength, shares of Alexion Pharmaceuticals (ALXN) have moved sharply lower over the course of the trading session on Wednesday. Alexion is currently do...

Deals and M&As this week: Alexion Pharmaceuticals, Recipharm, AstraZeneca

Alexion Pharmaceuticals has partnered with Complement Pharma for the co-development of pre-clinical complement inhibitor for neurodegenerative disorders. The two companies will...Read More... The pos...

M&As this week: Alexion Pharmaceutical, OvaScience

Alexion Pharmaceuticals has completed an acquisition of Syntimmune. Following the transaction, Syntimmune will add its clinical-stage drug candidate SYNT001 to Alexion’s...Read More... The post...

Alexion to Obtain Syntimmune for $400M up Front

Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) and Syntimmune have just today announced that Alexion will be acquiring Syntimmune, a company working to produce antibody therapeutics that focus on the neo...

Syntimmune Turns Drug For Rare Anemia Into $400M Alexion Buyout

Syntimmune, a biotech startup formed by the veteran founders of the hemophilia drug developer Syntonix, has been acquired by Alexion Pharmaceuticals for $400 million in cash up front. Syntimmune is ri...

Alexion Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report [Report Updated: 01052018] Prices from USD $175

Alexion Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance ReportSummaryAlexion Pharmaceuticals, Inc. Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data a...

Alexion Pharmaceuticals: TSI-Aufsteiger der Woche

Kulmbach ( - Alexion Pharmaceuticals-Aktienanalyse des Online-Anlegermagazins "Der Aktionär": "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie des US-Biotechkonzer....

Alexion’s Soliris successor in PNH unlikely to achieve price premium

Alexion Pharmaceuticals’ ALXN1210 for paroxysmal nocturnal hemoglobinuria (PNH) is unlikely to see a price premium to Alexion’s Soliris (eculizumab) once approved. However, a slight...Read Mor...

Drugs and Medications [271 Associated Drugs and Medications listed on BioPortfolio]

Pur-wash [Niagara Pharmaceuticals Inc.]


Bacitracin [Qualitest Pharmaceuticals]

Bacitracin Ointment, USP

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash Purified Water, 98.3% Ophthalmic Solution Eyewash

Antacid [Major Pharmaceuticals]

Major Pharmaceuticals Antacid Tablets Drug Facts

Eyewash station additive concentrate [Niagara Pharmaceuticals Inc.]


PubMed Articles [132 Associated PubMed Articles listed on BioPortfolio]

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective.

Chiral pharmaceuticals (CPs), including non-steroid anti-inflammatory drugs (NSAIDs), β-blockers and some herbicide and pesticides, are widely used in aquaculture, clinical treatment and many other f...

Assessment of 83 pharmaceuticals in WWTP influent and effluent samples by UHPLC-MS/MS: Hourly variation.

The removal efficiency of pharmaceuticals in wastewater treatment plants (WWTPs) is variable and some of these compounds pass these plants almost intact and others presenting a removal efficiency clos...

Letter--Incorporating Real-World Evidence and Patient Value Criteria into Value-Based Frameworks for Relapsed/Refractory Multiple Myeloma.

Orlowski has received research funding from Amgen, BioTheryX, Bristol-Myers Squibb, Celgene Corporation, and Takeda Pharmaceuticals; honoraria from Amgen, Bristol-Myers Squibb, Celgene Corporation, Ja...

Effects of pharmaceuticals on microbial communities and activity of soil enzymes in mesocosm-scale constructed wetlands.

Cyperus alternifolius based mesocosm-scale constructed wetland was employed to remove pharmaceuticals. We investigated the microbial community composition using phosphor lipid fatty acids (PFLAs) anal...

Clinical Trials [228 Associated Clinical Trials listed on BioPortfolio]

Bioequivalence Study of Torrent Pharmaceuticals Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic®20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sep...

Bioequivalence Study of Torrent Pharmaceuticals's Ltd's Nebivolol 20 mg Tablet

Subjects to compare the single dose bioavailability of Torrent's Nebivolol Tablets 20 mg and Bystolic 20 mg Tablets of Forest Pharmaceuticals Inc., USA. Dosing periods of studies were sepa...

Study Comparing Citalopram Hydrobromide Tablets 40 mg (Torrent Pharmaceuticals Ltd) and RLD Tablets 40 mg (Manufactured By Forest Pharmaceuticals Inc, Missouri) in 24+2 Normal Healthy Male Subjects in Fed Condition

- Objective: - The objective of this study is to compare the rate and extent of absorption of the Test Product, Citalopram Hydrobromide 40 mg (Torrent Pharmaceutical Li...

Bioequivalence Study of Torrent Pharmaceuticals Ltd.'s Rosuvastatin Calcium Tablets Under Fed Conditions

Subjects to compare the single dose bioavailability of Torrent's Rosuvastatin Calcium Tablets 40 mg and Crestor® 40 mg Tablets of AstraZeneca Pharmaceuticals LP, USA. Dosing periods of st...

Cilostazol 50 mg Tablets Under Fasting Conditions

This study will compare the relative bioavailability (rate and extent of absorption) of 50 mg Cilostazol Tablets manufactured by TEVA Pharmaceuticals Industries Ltd. and distributed by TEV...

Companies [1342 Associated Companies listed on BioPortfolio]

Alexion Antibody Technologies, Inc.

Alexion Antibody Technologies, Inc. (AAT) is a wholly owned subsidiary of Alexion Pharmaceuticals [ALXN]. AAT is engaged in discovering and developing a portfolio of antibody therapeutics targeting se...

Alexion Pharmaceuticals Incorporated

Alexion is a global biopharmaceutical company that combines groundbreaking science with a steadfast commitment to meeting the needs of patients living with severe, life-threatening and often ultra-rar...

Alexion Pharmaceuticals Inc.

Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with devastating and rare disorders. Alexion developed ...

Alexion Pharmaceuticals, Inc. and Dicerna Pharmaceuticals, Inc.

Alexion Pharmaceuticals, Inc.

Fourth Quarter 2011 Financial Highlights:

More Information about "Alexion Pharmaceuticals, Inc." on BioPortfolio

We have published hundreds of Alexion Pharmaceuticals, Inc. news stories on BioPortfolio along with dozens of Alexion Pharmaceuticals, Inc. Clinical Trials and PubMed Articles about Alexion Pharmaceuticals, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alexion Pharmaceuticals, Inc. Companies in our database. You can also find out about relevant Alexion Pharmaceuticals, Inc. Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record